Connected television (CTV) remains one of the fastest growing and most effective channels for pharmaceutical marketers to engage with their core customers. According to eMarketer, CTV is the most rapidly expanding ad channel in the US and is projected to grow 22.4%, reaching a total of $30.10 billion in 2024. Through privacy safe advanced targeting technology, high-value streaming inventory and the increased use of personalization, brands can better find and activate ideal DTC and HCP audiences at all phases of the diagnosis and treatment journey while consuming their preferred content.

During this conversation with leaders from Roku and Swoop, hear how the CTV landscape is changing, the advantages it gives pharma marketers and practical use cases that can be applied across your own advertising.